Design of New Chemicals Entities as Anti-inflammatory using Structure Optimization by Molecular Modeling Studies
DOI:
https://doi.org/10.7439/ijpc.v9i3.5220Keywords:
Nonsteroidal anti, Nonsteroidal anti, Nonsteroidal antiAbstract
The research on design of non toxic anti
Downloads
References
Atwal K, Ronyar G, Kinball S, Beyer B, Cucinotta G, Dimarco J, et al. Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5 pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. J Med Chem, 1990 Sep; 33(9):2629-35.
Grover G, Dzwonczyk S, Mcmullen D, Normadinam C, Selph P, Moreland S. Pharmacological profile of Dihydropyrimidine Calcium Chanel Bloker SQ 32,547 and SQ 32,946. J Cardiovasc Pharmacol, 1995 Aug; 26(2): 289.
Patil A, Kumar N, Kokke W, Bean M, Freyer A, De Brosse C, Mai S, et al. Novel Alkaloids from the Sponge Batzell sp.: Inhibitors of HIVgp120 Human CD4 Binding. J. Org. Chem. 1995 Mar; 60(5): 1182.
Dinakaran V, Jacob D, Mathew J. Synthesis and biological evaluation of novel pyrimidine-2(1H)-ones/thiones as potent anti-inflammatory and anticancer agents. Med Chem Res,2012; 21(11): 3598
Bahekar S, Shinde D. Synthesis and antiinflammatory activity of some [4, 6
Rainsford K , The ever
Dubois RW, Melmad GY, Laine L, Henning JM, Guidelines for the appropriate use of non
Modhave N, Chitre T, Pawar V, Synthesis and Evaluation of Anti-Inflammatory, Analgesic, Ulcerogenicity, and Nitric Oxide Releasing studies of Novel Pyrimidine Analogs as non-Ulcerogenic Derivatives. Int. J. Chem, Pharm, Sci. 2016 Aug; 4(8): 423-430.
Wey S, Augustyniak ME, Cochran ED, Ellis JL, Fang X, Garvey DS, et al. Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donors, J Med Chem, 2007 Dec; 50 (25): 6367
Muscara M, Wallace J, COX-inhibiting nitric oxide donors (CINODs): potential benefits on
cardiovascular and renal function, Cardiovasc Hematol Agents Med Chem 2006 May; 4(2):155
Chegaev K, Lazzarato L, Tosco P, Cena C, Marini E, Rolando B, et al. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1, 5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, J Med Chem, 2007 Apr; 50(7):1449
Chandak S, Bansode A, Murumkar P, Shinde M, Bothra K, Synthesis and investigation of antiinflammatory activity of novel nitric oxide donating hybrid drugs, Med Chem Res.2013 July; 22(35):3510-17.
VLIfeMDS, Molecular Design Suit Version 2.0, V
Indian, 2004, (www.Vlifesciences.com).
Halgren T, Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comp. Chem. 1996 Apr; 17:520
Ajmani S, Jadhav K, Kulkarni S, Three
Downloads
Published
Issue
Section
License
Copyright (c) 2019 International Journal of Pharmaceutical Chemistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.
How to Cite
